Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Alabama at Birmingham
Age
17–35
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Persons with first episode psychosis
Healthy controls will be matched to first episode psychosis participants on a one to one basis
You may not be if
inability to understand and sign informed consent assessed by the Evaluation to sign Consent form
diagnosable central nervous system illnesses
poorly controlled acute or chronic medical conditions aside from psychosis
history of head trauma with loss of consciousness for \> 2 minutes
active substance abuse or dependence (exclusive of nicotine dependence)
suspected substance induced psychotic symptoms
clinically significant symptoms of depression, hypomania, or mania
patients concomitantly treated with drugs known to affect glutamate, such as: valproate, topiramate, gabapentin, levetiracetam, lamotrigine, lithium, and acamprosate
